Results 21 to 30 of about 2,994,546 (307)

Cyanovirin-N Binds Viral Envelope Proteins at the Low-Affinity Carbohydrate Binding Site without Direct Virus Neutralization Ability

open access: yesMolecules, 2021
Glycan-targeting antibodies and pseudo-antibodies have been extensively studied for their stoichiometry, avidity, and their interactions with the rapidly modifying glycan shield of influenza A. Broadly neutralizing antiviral agents bind in the same order
Irene Maier   +2 more
doaj   +1 more source

Probing high affinity sequences of DNA aptamer against VEGF165. [PDF]

open access: yesPLoS ONE, 2012
Vascular endothelial growth factor (VEGF(165)) is a potent angiogenic mitogen commonly overexpressed in cancerous cells. It contains two main binding domains, the receptor-binding domain (RBD) and the heparin-binding domain (HBD). This study attempted to
Harleen Kaur, Lin-Yue Lanry Yung
doaj   +1 more source

Method for computing protein binding affinity [PDF]

open access: yesJournal of Computational Chemistry, 2004
AbstractA Monte Carlo method is given to compute the binding affinity of a ligand to a protein. The method involves extending configuration space by a discrete variable indicating whether the ligand is bound to the protein and a special Monte Carlo move, which allows transitions between the unbound and bound states.
Charles F. F. Karney   +2 more
openaire   +5 more sources

Computational Design of Nanobody Binding to Cortisol to Improve Their Binding Affinity Using Molecular Docking and Molecular Dynamics Simulations

open access: yesIndonesian Journal of Chemistry, 2022
Currently, nanobody binding cortisol has been deposited in the database. Unfortunately, the affinity is still in micromolar order. Substituting hydrophobic residues in the binding pocket and utilizing CDR2 and CDR3 is the strategy to improve the affinity.
Umi Baroroh   +4 more
doaj   +1 more source

Intracellular drug binding affinities by NMR [PDF]

open access: yesActa Crystallographica Section D Structural Biology, 2021
A commentary on the article by Luchinat et al. [(2021), Acta Cryst. D77, 1247–1258] where they describe an approach to identify the details of a compound binding to a molecular target using in-cell NMR to provide intracellular binding affinities.
openaire   +2 more sources

Learning Protein-Ligand Binding Affinity with Atomic Environment Vectors [PDF]

open access: yes, 2020
Scoring functions for the prediction of protein-ligand binding affinity have seen renewed interest in recent years when novel machine learning and deep learning methods started to consistently outperform classical scoring functions.
Andrew, Anighoro   +4 more
core   +2 more sources

Guanosine nucleotides regulate B2 kinin receptor affinity of agonists but not of antagonists: Discussion of a model proposing receptor precoupling to G protein [PDF]

open access: yes, 2000
The effect of nucleotides on binding of the B2 kinin (BK) receptor agonist {[}H-3]BK and the antagonist {[}H-3]NPC17731 to particulate fractions of human foreskin fibroblasts was studied.
Er Faussner   +3 more
core   +1 more source

Binding affinity and mechanisms of SARS-CoV-2 variants

open access: yesComputational and Structural Biotechnology Journal, 2021
During the rapid worldwide spread of SARS-CoV-2, the viral genome has been undergoing numerous mutations, especially in the spike (S) glycoprotein gene that encode a type-I fusion protein, which plays an important role in the infectivity and ...
Yanqiang Han   +4 more
doaj   +1 more source

PSnpBind-ML: predicting the effect of binding site mutations on protein-ligand binding affinity

open access: yesJournal of Cheminformatics, 2023
Protein mutations, especially those which occur in the binding site, play an important role in inter-individual drug response and may alter binding affinity and thus impact the drug’s efficacy and side effects.
Ammar Ammar   +3 more
doaj   +1 more source

GANsDTA: Predicting Drug-Target Binding Affinity Using GANs

open access: yesFrontiers in Genetics, 2020
The computational prediction of interactions between drugs and targets is a standing challenge in drug discovery. State-of-the-art methods for drug-target interaction prediction are primarily based on supervised machine learning with known label ...
Lingling Zhao   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy